Prescription drug · ANDA
Trazodone Hydrochloride NDC 51655-366
Trazodone hydrochloride 50 mg/1 · Tablet · Oral · Northwind Health Company, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 51655-366-26 | 51655036626 | 90 TABLET in 1 BOTTLE, PLASTIC (51655-366-26)Marketed from Jan 5, 2023 | |
| 51655-366-52 | 51655036652 | 30 TABLET in 1 BOTTLE, PLASTIC (51655-366-52)Marketed from Nov 30, 2022 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Trazodone Hydrochloride
- Generic name (nonproprietary)
- trazodone hydrochloride
- Active ingredients
- Trazodone hydrochloride — 50 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 071523
- Marketing start
- Listing expires
- Identifiers
- Product ID 51655-366_49daf198-ebf2-ddd1-e063-6394a90a54d7SPL ID 49daf198-ebf2-ddd1-e063-6394a90a54d7SPL set ID f2f2290f-b53c-3b38-e053-2995a90a157dRxCUI 856377UNII 6E8ZO8LRNM
- Pharmacologic class
- Serotonin Reuptake Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N451655036626followed by a unit qualifier and the quantityPackage 51655-0366-26. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Trazodone hydrochloride tablets are indicated for the treatment of major depressive disorder (MDD) in adults. Trazodone hydrochloride tablets are a selective serotonin reuptake inhibitor indicated for the treatment of major depressive disorder (MDD) ( 1 ).
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 071523
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Trazodone Hydrochloride | Trazodone hydrochloride 50 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-529 |
| Trazodone Hydrochloride | Trazodone hydrochloride 50 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-525 |
| Trazodone Hydrochloride | Trazodone hydrochloride 50 mg/1 | TabletOral | Unit Dose Solutions, Inc. | 87441-081 |
| Trazodone Hydrochloride | Trazodone hydrochloride 50 mg/1 | TabletOral | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-8371 |
| Trazodone Hydrochloride | Trazodone hydrochloride 50 mg/1 | TabletOral | Teva Pharmaceuticals USA, Inc. | 50111-560 |
| Trazodone Hydrochloride | Trazodone hydrochloride 50 mg/1 | TabletOral | Proficient Rx LP | 71205-568 |
| Trazodone Hydrochloride | Trazodone hydrochloride 50 mg/1 | TabletOral | AvKARE | 42291-868 |
| Trazodone Hydrochloride | Trazodone hydrochloride 50 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-2929 |